Zerodha (Trading & Demat Account)
FREE Equity Delivery and MF
Flat ₹20/trade Intra-day/F&O
Zerodha (Trading & Demat Account)
FREE Equity Delivery and MF
Flat ₹20/trade Intra-day/F&O
|
|
Comparision between Indian Bank IPO and SMS Pharmaceuticals IPO.
Indian Bank IPO is a Mainline Book Built Issue IPO proposed to list at BSE, NSE while SMS Pharmaceuticals IPO is a Mainline Book Built Issue proposed to list at BSE, NSE.
| Indian Bank IPO | SMS Pharmaceuticals IPO | |
|---|---|---|
| Logo |  |
 |
| Issue Category | Mainline | Mainline |
| Issue Type | IPO | IPO |
| Process Type | Book Built Issue | Book Built Issue |
| Listing At | BSE, NSE | BSE, NSE |
| Lead Managers | Axis Capital Limited ICICI Securities Limited Kotak Mahindra Capital Company Limited SBI Capital Markets Limited |
Uti Securities Ltd |
| Registrar | Cameo Corporate Services Limited | Aarthi Consultants Pvt Ltd. |
| Market Maker | ||
| DRHP | DRHP  |
DRHP |
| RHP | RHP |
RHP |
| Anchor Investor | ||
| IPO Allotment URL | IPO Allotment URL |
IPO Allotment URL |
The total issue size of Indian Bank IPO is up to ₹782.15 Cr whereas the issue size of the SMS Pharmaceuticals IPO is up to ₹97.93 Cr. The final issue price of Indian Bank IPO is ₹91.00 per share and of SMS Pharmaceuticals IPO is ₹380.00 per share.
| Indian Bank IPO | SMS Pharmaceuticals IPO | |
|---|---|---|
| Face Value | ₹10 per share | ₹10 per share |
| Issue Price (Lower) | ₹77.00 per share | ₹360.00 per share |
| Issue Price (Upper) | ₹91.00 per share | ₹380.00 per share |
| Issue Price (Final) | ₹91.00 per share | ₹380.00 per share |
| Discount (Retail) | ||
| Discount (Employee) | ||
| Market Lot Size | 75 shares | 15 shares |
| Fresh Issue Size | ||
| Fresh Issue Size (Amount) | ||
| OFS Issue Size | ||
| OFS Issue Size (Amount) | ||
| Issue Size Total | 8,59,50,000 shares | 25,77,000 shares |
| Issue Size Total (Amount) | up to ₹782.15 Cr | up to ₹97.93 Cr |
Indian Bank IPO opens on Feb 05, 2007, while SMS Pharmaceuticals IPO opens on Feb 05, 2007. The closing date of Indian Bank IPO and SMS Pharmaceuticals IPO is Feb 09, 2007, and Feb 08, 2007, respectively.
| Indian Bank IPO | SMS Pharmaceuticals IPO | |
|---|---|---|
| Anchor Bid Date | ||
| Issue Open | Feb 05, 2007 | Feb 05, 2007 |
| Issue Close | Feb 09, 2007 | Feb 08, 2007 |
| Basis Of Allotment (Tentative) | ||
| Initiation of Refunds (Tentative) | ||
| Credit of Share (Tentative) | ||
| Listing date (Tentative) | ||
| Anchor Lockin End date 1 | ||
| Anchor Lockin End date 2 |
Indian Bank IPO P/E ratio is , as compared to SMS Pharmaceuticals IPO P/E ratio of .
| Indian Bank IPO | SMS Pharmaceuticals IPO | |
|---|---|---|
| Financial | ||
| Promoter Shareholding (Pre-Issue) | ||
| Promoter Shareholding (Post-Issue) | ||
| P/E Ratio | ||
| Market Cap | ||
| ROE | ||
| ROCE | ||
| Debt/Equity | ||
| EPS | ||
| RoNW |
In the Indian Bank IPO retail investors (RII) are offered while in SMS Pharmaceuticals IPO retail investors are offered . Qualified institutional buyers (QIB) are offered in Indian Bank IPO and in SMS Pharmaceuticals IPO.
| Indian Bank IPO | SMS Pharmaceuticals IPO | |
|---|---|---|
| Anchor Investor Reserveration | ||
| Market Maker Reserveration | ||
| QIB | ||
| NII | ||
| RII | ||
| Employee | ||
| Others | ||
| Total |
Indian Bank IPO subscribed 32.16x in total, whereas SMS Pharmaceuticals IPO subscribed 2.64x.
| Indian Bank IPO | SMS Pharmaceuticals IPO | |
|---|---|---|
| QIB (times) | 56.45x | 3.47x |
| NII (times) | 8.36x | 0.28x |
| Big NII (times) | ||
| Small NII (times) | ||
| RII (times) | 3.18x | 2.47x |
| Employee (times) | 0.63x | |
| Other (times) | ||
| Total (times) | 32.16x | 2.64x |
Add a public comment...
FREE Intraday Trading (Eq, F&O)
Flat ₹20 Per Trade in F&O
|
|
